Skip to content
HowShorted

aTyr Pharma, Inc. short interest in 2023

In 2023, aTyr Pharma, Inc.'s disclosed short interest ran from 0.83% of shares outstanding on 13 Jan 2023 to 0.36% on 29 Dec 2023, a change of -0.47 percentage points. The year's high was 1.45% on 15 Feb 2023 and its low 0.32% on 15 Nov 2023, averaging 0.68% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.56 days on 31 Aug 2023. Full history: aTyr Pharma, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for aTyr Pharma, Inc. in 2023

2023 in figures

Start of year
0.83% (13 Jan 2023)
End of year
0.36% (29 Dec 2023)
Change
-0.47 pp
High
1.45% (15 Feb 2023)
Low
0.32% (15 Nov 2023)
Average
0.68%
Highest days to cover
2.56 (31 Aug 2023)
SEC filings marked
8

Every report in 2023

aTyr Pharma, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20230.83%1.64
31 Jan 20230.81%1.78
15 Feb 20231.45%1.00
28 Feb 20230.89%1.00
15 Mar 20230.45%1.00results (8-K), 10-K filed
31 Mar 20230.77%1.04
14 Apr 20230.75%1.09
28 Apr 20230.56%1.00
15 May 20230.77%1.0010-Q filed, results (8-K)
31 May 20230.80%1.00
15 Jun 20230.86%1.46
30 Jun 20230.92%1.00
14 Jul 20230.89%1.69
31 Jul 20230.78%1.44
15 Aug 20230.73%1.3010-Q filed, results (8-K)
31 Aug 20230.77%2.56
15 Sep 20230.72%1.84
29 Sep 20230.42%1.55
13 Oct 20230.38%1.43
31 Oct 20230.41%2.11
15 Nov 20230.32%1.1310-Q filed, results (8-K)
30 Nov 20230.34%1.21
15 Dec 20230.33%1.00
29 Dec 20230.36%1.00

See also: aTyr Pharma, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.